The production of recombinant glycoprotein therapeutics requires characterization of glycosylation with respect to the lot-to-lot consistency. Here we introduce the 'hypothetical N-glycan charge Z' as a parameter that allows to characterize the protein glycosylation in a simple, however, efficient manner.
Introduction
In aiming for parameters that ensure the lot-to-lot consistency of (recombinant) glycoproteins, we have defined a theoretical number that reflects the composition of the relinked carbohydrates. These are known to normally consist in bi-, tri-, and tetraantennary structures, the antennae of which usually terminate with negatively charged sialic acid residues attached to /3-linked galactose. These sialic acid residues play an important role with respect to the in vivo half-life of a (therapeutic) glycoprotein and thus influence its biological efficacy.
In order to guarantee the lot-to-lot consistency of a (recombinant) glycoprotein with respect to its in vivo halflife as well as its biological efficacy, parameters have to be defined that ensure the integrity of the N-glycan pattern as well as the degree of sialylation and reflect the carbohydrate microheterogeneity. The routine sialic acid determination of (recombinant) glycoproteins is part of registration works as well as of stability studies. It enables to calculate the degree of sialylation and allows to judge the in vivo clearance rate that has to be expected.
Although the sialic acid content-expressed as mol Neu5Ac per mol of glycoprotein (peptide bone)-is a very useful figure, its accuracy is hampered by (i) the accuracy of the sialic acid determination and (ii) the accuracy of the protein determination. In fact, the protein determination of glycoproteins is not an easy task and may vary dramatically due to the carbohydrate content as well as from method to method (such as, e. g., UV determination, Lowry assay, BCA assay, amino acid determination). Thus, the degree of sialylation will vary according to the method used. In addition, the coefficients of variation of each determination (i. e., the sialic acid, the monosaccharide component and the protein determination) will add to the uncertainty of the degree of sialylation (mol Neu5Ac/mol Gal).
We have now found that a number 'Z' that reflects the hypothetical N-glycan charge is a much better and more reliable parameter to ensure the biological safety as well as the therapeutical efficacy of (recombinant) glycoproteins. This parameter is usually measurable with a degree of variation of less than 3% and reflects not only the negative charge carried by sialic acid residues but also the charge introduced by sulfate (and phosphate) groups.
The hypothetical N-glycan charge of the glycoprotein is deduced from the N-glycan mapping profile obtained via HPAE-PAD. In HPAEC, N-glycans are first separated according to their charge, exhibiting retention times in the range of 13-18 min (asialo, as), 20-23 min (monosialo, MS), 27-32 min (DiS), 34-38 min (TriS), and 40-43 min (TetraS structures), using the validated gradient 'S' for sialylated N-glycans (Hermentin et al., 1992a) . As the response factors of the distinct N-glycans may be regarded as comparable (Lee, 1990) , the area under the curve (A) in the monosialo region is equivalent to the charge carried by the monosialylated N-glycan structures appearing in the monosialo region of the chromatogram. The area in the disialo region, multiplied by 2, is equivalent to the charge carried by the disialylated N-glycan structures; the area in the trisialo region, multiplied by 3, is equivalent to the charge carried by the trisialylated N-glycan structures; the area in the tetrasialo region, multiplied by 4, is equivalent to the charge carried by the tetrasialylated N-glycan structures; and the area in the pentasialo region, multiplied by 5, is equivalent to the charge carried by the pentasialylated N-glycan structures. In analogy, the area in the asialo region reflects the amount of neutral structures, carrying a net-charge of zero. 'Z' is defined as the sum of the products of the various areas, multiplied by the respective charge: Z = /4(asialo)*0 + ^(MS)'! + ^(DiS)ŵ here i is 0 in the asialo region, 1 in the monosialo (MS) region, 2 in the disialo (DiS) region, 3 in the trisialo (TriS) region, 4 in the tetrasialo (TetraS) region, and 5 in the pentasialo (PentaS) region.
Results and Discussion
Rhu IL-4R (Idzerda et al., 1990; Enssle et al., 1995) and rmur IL-4R (Mosley et al., 1989) , expressed in CHO and BHK cells, respectively, are research and developmental products of Behringwerke AG and therefore used as model glycoproteins. In the course of this investigation, the IL-4R production was optimized with respect to clone expression, culture conditions and mode of fermentation, taking Z as one of the parameters used for the assessment of protein glycosylation (unpublished data). Thereby, Z turned out to be one of the most predictive and reliable parameters of protein glycosylation available to date, enabling to describe the glycosylation status of the respective glycoprotein in a simple number. The reproducibility and reliability of Z determination was ascertained by extensive validation experiments, some of which are communicated in this report. Consequently, the determination of Z was extended to a number of human serum as well as non-human glycoproteins, the Z values of which are also communicated. It is suggested that the hypothetical N-glycan charge Z of a glycoprotein may be regarded as a new and very helpful parameter that enables judgement of the protein glycosylation in a simple but efficient manner. PNGase F release, The repetitive automated hydrazinolysis of rhu IL-4R (lot E4-930914) with 1.0 mg of sample per reactor provided Z = 201 ± 2.8 (CV = 1.4%) (n = 18) (for a representative mapping profile see Figure 1 ; the corresponding calculation of Z is outlined in Table I ), whereas Z = 194 ± 4.5 (CV = 2.3%) (n = 18) was obtained, using 0.5 mg of rhu IL-4R (Table II) . These values proved to be comparable with the Z values derived via PNGase F-digestions in the presence or absence of CHAPS, with and without the previous digestion of the glycoprotein with trypsin or Lys C, providing an average of Z = 204.5 ± 3.4 (1.7%) (Table II) .
Validation experiments Z and the validity of automated hydrazinolysis versus
Rhu IL-4R from the second cell line (Bl 1-930406), produced under identical culture and work-up conditions, provided Z = 235 ± 2.6 (CV = 1.1 %) (n = 10) upon hydrazinolysis and Z = 243 after PNGase F treatment in the presence or absence of 0.5% CHAPS (Table II) .
The various Z values proved to be very similar, irrespective of whether the N-glycan pool was gained via automated hydrazinolysis or via PNGase F treatment. It is noteworthy that the hydrazinolysis-derived glycan pool had to be desalted prior to Z determination.
The differences in the Z values obtained for the two clones (Table II) , although produced under identical production and work-up conditions, clearly indicated differences in the respective clone-specific glycosylation.
Z and the PNGase F digestion of AGP AGP is known to resist PNGase F digestion, unless the conditions are carefully optimized (Nuck et ai, 1990) . In order to see whether the incomplete digestion of AGP could be proven via Z, AGP was digested with PNGase F for a period of 48 h, applying the conditions described for rhu EPO, and compared to the hydrazinolysis-derived and trypsin/PNGase F-derived N-glycan pool (Figure 2 ). Whereas the hydrazinolysis-derived N-glycan pool ( Figure  2 , run a) and the trypsin/PNGase F-derived N-glycan pool (Figure 2 , run c) provided Z = 289, each, the hypothetical N-glycan charge was clearly reduced when AGP was digested by PNGase F without any detergent (i.e., EPO conditions) (Z = 248; Figure 2 , run b). Moreover, the HPAE-PAD mapping profile suggested difficulties for the enzyme in cleaving the tetraantennary tetrasialylated (C4-4*) structures (Figure 2, run b) . Thus, the chromatogram revealed C3-235300 (the triantennary disialylated isomer[s]) as the highest peak, and the peaks in the C4-4* region were clearly reduced, whereas the ratio of the C3-3* and C4-3* structures (Hermentin etal., 1992b) appeared 'normal', i.e., comparable with the hydrazinolysis-derived mapping profile (Z = 289; Figure 2 , run a) as well as with the tryptic/PNGase F-derived mapping profile (Z = 289; Figure 2 , run c).
Z and the consistency control of protein glycosylation Z and the comparison of various A GP-derived N-glycan pools
Various samples of AGP-derived N-glycan pools have previously been compared on the basis of their respective HPAE-PAD mapping profiles, in order to evaluate the loss of terminal sialic acid, due to different N-glycan release, work-up and storing conditions (Hermentin et ai, 1992b, Figure 5 ). As reported, approximately 40 distinct peaks and free Neu5Ac (~3 mol%) could be detected in a hydrazinolysis-derived N-glycan pool (a 50 mg batch; Hermentin et ai, 1992b, Figure 5, run b) , whereas only about 30 distinct peaks were detected in a PNGase Fderived N-glycan pool, while the amount of free sialic acid was negligible (Hermentin et ai, 1992b, Figure 5 , run e). The amount of free Neu5Ac detected by HPAE-PAD in the various preparations decreased in the order of run a (LB-001; OGS) > run b (50 mg hydrazinolysis batch) > run c (1000 mg hydrazinolysis batch) > run d (2 mg batch, GlycoPrep 1000) > run e (PNGase F-derived N-glycan pool, obtained after tryptic AGP digest). Concomitant with the decrease of free Neu5Ac, going from run a to run d, the HPAE-PAD chromatograms increasingly resembled the PNGase F-derived N-glycan pool (run e), with the closest resemblance achieved with the GlycoPrep 1000 (run d) (Hermentin et al., 1992b) . At that time, a comparison of these various N-glycan pools was not possible without the presentation of the corresponding mapping profiles (Hermentin et al., 1992b, Figure 5) .
In order to prove the usefulness of the hypothetical Nglycan charge for the appropriate characterization of Nglycosylation, Z was retrospectively calculated for each of these samples from the respective HPAE-PAD mapping profiles (Hermentin et al., 1992b, Figure 5) , and these results are summarized as follows: Z = 248 for run a (LB-001, OGS), Z = 262 for run b (50 mg hydrazinolysis batch), Z = 276 for run c (1000 mg hydrazinolysis batch), Z = 285 for run d (2 mg batch, GlycoPrep 1000), and Z = 289 for run e (trypsin/PNGase F-derived N-glycan pool). Thus, the increase of Z clearly corresponded with the decrease in the loss of sialic acid (going from run a to run d). The GlycoPrep-derived N-glycan pool (Hermentin et al., 1992b , Figure 3 , run d; Z = 285) exhibited Z almost identical to the trypsin/PNGase F-derived N-glycan pool (Hermentin et al., 1992b, Figure 3 , run e; Z = 289), suggesting their virtual identity.
17.4%; n = 11) and a hypothetical N-glycan charge of Z = 138,7 ± 6.9 (CV = 5,0%; n = 13). Due to its higher accuracy, the Z determination appeared to be more reliable than the sialic acid content determination, most likely as Z is independent of the protein determination. As the validation experiments have shown that the determination of Z is highly accurate, with CV < 3% (Table II) , the higher variation of Z for the pilot plant production/mAb purification (CV = 5.0%; Table III ) is due to slight, but tolerable, inconsistencies of the 11 production lots (R007-R017).
The conventional chromatographic purification process was designed such that it should remove the lower-charged glycoforms, which were expected to increase the clearance rate of the material in the liver (compare the results of rmur IL-4R, summarized in Table IV) . Indeed, the chromatographic purification provided higher sialic acid contents (average: 10.3 ± 0.5 mol/mol; CV = 5.1%; n = 11) and higher Z values (average: Z = 176.3 ± 7.2; CV = 4.1 %;n = 11), as was intended. Again, the Zdetermination appeared to be slightly more accurate than the sialic acid content determination. The variation of Z was slightly reduced to CV = 4.1% (versus CV < 3% during validation), proving the high lot-to-lot consistency of the purified rhu IL-4R materials.
Z and the lot-to-lot consistency of rhu IL-4R
Samples of 11 successive harvests of rhu IL-4R (CHO) production in a pilot plant (R007-R017) were worked up, employing conventional chromatographic steps (unpublished data) as well as small scale monoclonal antibody affinity chromatography, and were analyzed with respect to sialic acid content and Z determination. As can be seen from Table III , the mAb-purified materials provided an average sialic acid content of 6.9 ±1.2 mol/mol (CV =
Z and the glycoprotein clearance in vivo, exemplified with rmur IL-4R (BHK)
A preparation of rmur IL4R (BHK) was passed over a column of Q-Sepharose FF and collected in 5 fractions ( Figure 3 ). The isoelectric focusing of the fractions revealed dramatic differences in the patterns of the glycoforms for fractions Ql to Q4, while fractions Q4 and Q5 proved to be indistinguishable ( Figure 4 ). The relevant analytical data of these fractions are summarized in Table  IV . The sialic acid content was found close to zero in fraction Ql (13.6 /Ag/mg) and increased up to fraction Q4 (109.5 /Ag/mg), while it remained constant in fraction Q5 (108.6 /ig/mg).
In theory, the Neu5Ac/Gal ratio (i.e., the degree of sialylation) should reflect the in vivo clearance via the Gal receptors of the liver, whereas the Man/Gal ratio should permit to predict the clearance behavior via the high-mannose receptors present in the liver and on macrophages.
The degree of sialylation therefore should allow prediction of the in vivo half-life of glycoproteins, relative to an appropriate standard. However, as the degree of sialylation is determined from two independent assays, the Neu5Ac and Gal determination, respectively, its coefficient of variation is dependent from the CV values of both tests. Hence, a more reliable parameter would be appreciated that would allow to predict the clearance behavior of glycoproteins in a more accurate manner. As may be seen from Table  IV , the hypothetical N-glycan charge proved to be more predictable in that regard.
The degree of sialylation (Neu5Ac/Gal; mol/mol) was found to be lowest in fraction Ql (0.20) and increased steadily up to fraction Q4 (0.67), whereas it slightly decreased again in fraction Q5 (0.63). The ratio of Man/ Gal (mol/mol) was used to judge the ratio between high mannose and complex type structures. The Man/Gal ratio proved to be highest in fraction Ql (3.02 mol/mol), reveal- ing a significant amount of high mannose-type structures. It decreased to 1.04 mol/mol in fraction Q4 and remained comparable in fraction Q5 (0.98 mol/mol), which reflected, at an average, the presence of triantennary complex type structures and the absence of high-mannose type structures. As the degree of both the asialo and high mannose type structures goes into the calculation of Z (Eq. 1), the hypothetical N-glycan charge should reflect the contributions to the clearance of both. Therefore, Z should better reflect the clearance behaviour of a glycoprotein in vivo than any other of the analytical parameters summarized in Table IV . As expected, Z proved to be smallest in fraction Ql (Z = 147), and increased to fraction Q4 (Z = 248). Similarly, the in vivo clearance in mice, expressed as AUD values (Table IV) , was found to be smallest in fraction Ql (AUD = 0.8) and increased to fraction Q4 (AUD = 63.7) and Q5 (AUD = 85.9), revealing the instant removal of the Ql material from the circulation via the galactose and mannose receptors available in the mouse system. Note: Z could not be determined for fraction Q5 due to the lack of sufficient amounts of material. In comparison with the other analytical data, the AUD value of fraction Q5 appeared too high; however, the measurement could not be repeated for the same reason. Moreover, it needs to be mentioned that the AUD values were determined from a single mouse each, for animal protection reasons, which makes the AUD values somewhat questionable. Therefore, Z determination may be regarded as an analytical alternative that should enable doing without the highly costly and contested in vivo clearance studies.
Z and the IL-4R stability upon storage In order to determine how long culture supernatants of the rhu IL-4R (CHO) fermentation could be stored prior to work-up, aliquots of the culture supernatant of the pilot plant were kept at RT, +4°C, -20°C, and -70°C for periods of up to 3 months. After incubation the samples were purified by immunoaffinity chromatography, and the stability of IL-4R was assessed, among other parameters (not shown), via sialic acid and Z determination. As can be seen from Figure 5a , the hypothetical N-glycan charge appeared to be constant for aliquots stored at -70°C or even -20°C, however, decreased upon storage at RT or +4°C, which clearly indicated the loss of charge upon storage without freezing. Indeed, the sialic acid content dropped analogously (Figure 5b ), indicating that the decrease of Z was attributable to the loss of sialic acid. However, the sialic acid results appeared to be less reliable and less accurate, suggesting the superior reproducibility and accuracy of Z determination.
Z determination of distinct glycoproteins rhu EPO (from CHO and BHK cells)
The carbohydrate analysis of rhu EPO, originally described by Sasaki et al. (1987) and Takeuchi et al. (1988) for rhu EPO (CHO) and by Tsuda et al. (1988) for rhu EPO (BHK), has recently been extended by studies of Hokke et al. (1995) and Watson et al. (1994) (for CHO-EPO) and Nimtz et al. (1993) (for BHK-EPO). As rhu EPO is known to consist of mainly tetraantennary structures with 0-3 LacNAc repeats (Takeuchi and Kobata, 1991) , Z should amount to a number between 300 and 400. Indeed, the hypothetical N-glycan charge of CHO-EPO (Boehringer Mannheim) was determined to Z = 361 ± 2 (CV = 0.6%) (n = 6; three different experiments with 2 HPAE-PAD runs, each), and the N-glycan charge of BHK-EPO (Merckle) was determined to Z = 323 ± 2 (CV = 0.7%) (n = 4; four different lots; four different experiments; one HPAE-PAD run, each) (Table V) . Thus, the smaller Z value of the BHK-EPO from Merckle clearly reflected the greater share of undersialylated N-glycans: 34% of the Rem. N-glycans were missing one and 12% of the N-glycans were missing two terminal sialic acid residues; the structures consisted in 40.9 % tetrasialylated, 35.0 % trisialylated and 21.1 % disialylated structures (Nimtz et al., 1993) . These data from the literature allowed calculation of the N-glycan charge to Z = 311, which is in good agreement (deviation <4%) with the N-glycan charge determined according to Equation 1, i.e., Z = 323, using the same rhu EPO (BHK) from Merckle.
On the other hand, in the CHO-EPO from Amgen the major (>95%) di-, tri-and tetraantennary structures were fully sialylated (Watson et al., 1994) . Their separation according to charge of the PNGase F-released N-glycans (using a Glycopak DEAE column) allowed to calculate the N-glycan charge to Z = 367, which is in excellent agreement with the glycan charge of the EPO (CHO) from Boehringer Mannheim, used in this study (Z = 361).
In contrast, in the study of Hokke et al. (1995) , which used CHO-EPO from Organon Teknika, 18-20% of the N-glycans were missing one and 3% of the N-glycans were missing two sialic acid residues. Their structural analysis enabled to calculate the N-glycan charge to Z = 286, which proved to be significantly smaller than the CHO-EPO from Amgen (Z = 367) and Boehringer (Z = 361) as well as the BHK-EPO from Merckle (Z = 323). This undersialylation observed for the CHO-EPO from Organon (Z = 286) could be attributable to differences in the distinct cell line used, the production process, and the respective work-up conditions. Most important, however, it may be speculated that it should result in a reduced half-life (due to clearance via asialo receptors of the liver) and, hence, in a reduced bioactivity.
Thus, the N-glycan charge appears as a very helpful number that enables judgement of the glycosylation status of different EPO preparations, and the same should hold true for other glycoproteins.
Bovine serum fetuin
For bovine serum fetuin, Green et al. (1988) have assigned 23 distinct N-linked oligosaccharides, 3% of which were mono, 35% were di-, 54% were tri-, and 8% were tetrasialylated structures. From these data, a hypothetical N-glycan charge of Z = 267 may be anticipated. Uncertainties of course arise from the occurrence on fetuin of O-glycans (Spiro and Bhoyroo, 1974) , which show up in the HPAE-PAD chromatogram as the 'peeled' disaccharide Neu5Aca 2,3Gal (Hermentin et al., 1994) as a peak at 22.5 min (in the monosialo-region) (see Hermentin and Witzel, 1993 ; Figure 9 , run f). In a distinct set of experiments the largescale (0.5 g) hydrazinolysis-derived glycan pool of fetal calf serum fetuin was desalted via Sephadex G-25, which resulted in the removal of most of the O-glycans (Hermentin et al., 1994) . When the integration of the residual 'degraded O-glycan'-peak in the HPAE-PAD chromatogram (at 22.5 min) was suppressed via the software, the hypothetical N-glycan charge was determined to Z = 256 (Table  V) , which was only 4% less then the one calculated from the data provided by Green et al. (1988) (i. e., Z = 267).
In a different experiment, the automated hydrazinolysisderived glycan pool of bovine (instead of fetal calf) serum fetuin was mapped via HPAE-PAD without prior desalting, and Z was calculated according to Equation 1, taking the 'degraded O-glycan'-peak as monosialylated glycan, which provided Z = 290 (Table V) . It is obvious that special care has to be taken when using the hydrazinolysis-derived glycan pools of glycoproteins carrying O-glycans. In addition, the determination of Z for bovine fetuin is hampered by the occurrence of antennary Gal/31,3Glc-NAc (instead of Gal/31,4GlcNAc), concomitant with the presence of Neu5Ac attached to antennary GlcNAc (see Green et al, 1988 , and references cited therein), which complicates the Z calculation. However, in the case of fetuin, where the groups of glycan peaks are clearly separated (see Hermentin and Witzel, 1993;  Figure 9 , run f), Z may be calculated without any difficulties.
Hen ovomucoid
The carbohydrate moieties of hen ovomucoid were reported to consist almost exclusively in bisected trunkated complex type N-glycan structures (see, e.g., Yamashita et al, 1982 Yamashita et al, , 1983 . Therefore, Z should be expected to be close to zero. Indeed, the mapping profile of the chicken ovomucoid N-glycan pool LB013 (OGS) (see Hermentin and Witzel, 1993 ; Figure 9 , run b) provided Z = 15 (Table  V) , which reflects the absence of charged structures.
Bovine pancreas ribonulease B
The complete structural characterization of the oligosaccharides from bovine pancreas ribonulease B has recently been described (Liang et al., 1980 ; for a recent study, see Fu et al., 1994 , and references cited therein), revealing a unique nature of high mannose type structures. The mapping profile of the bovine pancreas ribonulease B N-glycan pool LB009 (OGS) (see Hermentin and Witzel, 1993; Figure 9 , run a) provided Z = 15 (Table V) , due to small spikes in the monosialylated region, which could be impurities of the hydrazinolysis-derived glycan pool.
Porcine thyroglobulin
The determination of Z for the carbohydrate chains of porcine thyroglobulin (Yamamoto et al., 1981 ) is made more difficult by the occurrence of monosialylated sulfated N-glycans and by the fact that 8% of the major structures carry Neu5Gc instead of Neu5Ac (de Waard et al., 1991) . The hypothetical N-glycan charge was determined from the mapping profile of glycan pool LB-011 (OGS) (see Hermentin and Witzel, 1993;  Figure 9 , run c), which proved to be devoid of any tri-and tetrasialylated structures (apart from a few spikes which could be regarded as impurities or artefacts), yielding Z = 82 (Table V) .
Human serum glycoproteins
Most of the human serum glycoproteins examined (Table  V) have thus far not been analyzed with respect to their distinct N-glycan structures. Some of their features may be gained from reviews of Baenziger (1984) , Schwick and Haupt (1984) , Haupt (1990), and Turner (1992) .
a r Acid glycoprotein
The major N-glycan structures of a r acid glycoprotein have been elucidated (after desialylation) by Fournet et al. (1978) and Yoshima et al. (1981) as being mainly tri-and tetraantennary structures with and without antennary fucose, and additional minor components have recently been assigned by comparison with structures contained in an HPAE-PAD and a HPCE mapping database (Hermentin etal., 1992b (Hermentin etal., , 1994 . Due to the occurrence of branch fucosylation, which makes the fucosylated N-glycans elute about 4 min faster (Hermentin et al, 1992b) , the calculation of Z for AGP proved to be more sophisticated than with the other glycoproteins of Table V . Thus, tetrasialylated C4-4* structures, upon the introduction of antennary fucose, will appear in or near the group of peaks of the trisialylated C4-3*/C3-3* structures, which again, upon fucosylation, will shift versus the group of peaks of the disialylated C4-2*/C3-2*/C2-2* structures (Hermentin etal, 1992b) . Therefore, the AGP-derived N-glycan pool did not result in the clearly separated groups of peaks normally seen. Bearing these AGP-related complications in mind, the integration of the groups of peaks was chosen such that the most valid integration was achieved rather than to reflect the de facto charge carried by the respective N-glycan peaks. Thus, the hypothetical N-glycan charge of AGP lot 281184 was determined to Z = 289 (Table V) . As the glycosylation of AGP is known to change during inflammation (De Graaf et al, 1993) , it is predicted that the Z values of AGP of individuals may be regarded as numbers that correlate with the status of the inflammation process.
Human fibrinogen
According to Townsend et al (1982) , human fibrinogen contains four biantennary oligosaccharide chains which are partially desialylated. These data should amount to Z 2 00, and Z = 184 was in fact obtained for the human fibrinogen N-glycan pool LB012 from OGS (Table V) . However, the mapping pattern (see Hermentin and Witzel, 1993 ; Figure 9 , run e) looked much more complex than should be expected from the data of Townsend etal. (1982) , which needs further evaluation.
Human serum transferrin
Similarly, human serum transferrin is known to carry mostly the C2-224300.02 glycan structure (Spik et al, 1975) , and hence a glycan charge in the range of 200 should again be expected. Indeed, the mapping profile of the transferrin N-glycan pool LB010 (OGS) revealed C2-224300.02 as the predominant structure (see Hermentin and Witzel, 1993;  Figure 9 , run d), and the glycan charge was calculated to Z = 207 (Table V) . In contrast to AT III, the occurrence of traces of tri-and tetrasialylated structures was also observed, elevating Z to >200. As tetraantennary structures have thus far not been described for human serum transferrin, the spikes detected in the tetrasialylated region of the mapping profile (Hermentin and Witzel, 1993) may be regarded as artefacts of the distinct transferrin N-glycan pool used (LB010, OGS). The glycosylation of transferrin is known to change in alcohol abuse (Turner, 1992; De Jong et al, 1995; Landberg et al, 1995) . It is predicted that the Z values of transferrin of individuals will correlate with the status of alcohol abuse.
Human antithrombin HI
Human antithrombin III is known to carry only biantennary complex-type N-glycans, of which 70% are disialyated and 30% are monosialyated structures (Mizuochi et ai, 1980; Franzen et ai, 1980) . These data should amount to a hypothetical N-glycan charge of Z = 170. Indeed, Z = 170 was determined from the AT III N-glycan pool obtained via large-scale hydrazinolysis (performed at OGS), whereas Z = 180 was obtained after automated hydrazinolysis, using the GlycoPrep 1000 (Table V) .
Additional human serum glycoproteins
Various other human serum glycoproteins, such as a r T glycoprotein, a r antitrypsin, a r antichymotrypsin, ft-glycoprotein-I, TBG-glycoprotein, a,-B glycoprotein, c^-HS glycoprotein, 8S-a 3 glycoprotein, and haptoglobulin (for further information see the reviews of Baenziger, 1984; Schwick and Haupt, 1984; Haupt, 1990) , have been subjected to automated hydrazinolysis, and the respective Z values are summarized in Table V .
With the exception of AGP (Z = 289), a,-antichymotrypsin (Z = 236), TBG-glycoprotein (Z = 208) and serotransferrin (Z = 207), the human serum glycoproteins measured so far proved to exhibit Z < 200, with Z ranging between Z = 145 (8S-a 3 glycoprotein) and Z = 197 (haptoglobulin). The corresponding HPAE-PAD mapping profiles (not shown) revealed the absence of peaks in the tetrasialylated region for a,-T glycoprotein, a,-antitrypsin, ft-glycoprotein-I, TBG-glycoprotein, a,-B glycoprotein, a 2 -HS glycoprotein, and 8S-a 3 glycoprotein. Moreover, for these glycoproteins, the disialyated (DiS) region proved to be in the range between 50% («2-HS glycoprotein) and 75% (a r antitrypsin), suggesting the disialylated biantennary (C2-2*) structure(s) as the dominate N-glycan(s) of most of the human serum glycoproteins.
General discussion
The demand for reproducible, fast, and facile carbohydrate analysis is increasing steadily. However, the more detailed assignment of protein N-glycosylation comprised, up till now, a costly and time-consuming structural analysis, which required expertise and infrastructure for methylation analysis/GC-MS, FAB-MS, and high resolution 'H-NMR spectroscopy. We have recently pointed out that an alternative appears attractive that should allow reduction of these highly costly and time-consuming demands of carbohydrate structural analysis by using standard separation techniques and affordable hardware (Hermentin et ai, 1992a (Hermentin et ai, , 1994 . High-pH anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) fulfills the criteria for a quick, reliable, and cheap routine standard separation technique that enables the lot-to-lot consistency control of recombinant glycoproteins (Conradt et ai, 1991) as well as the structural assignment of N-glycans by mere comparison of retention times (Hermentin et al. 1992a,b) .
In HPAE-PAD, the separation is achieved under alkaline conditions by the use of an anion exchange column, which separates the isolated N-glycans primarily according to charge, i.e., the number of sialic acid residues (Lee, 1990; Conradt et ai, 1991; Townsend and Hardy, 1991; Hermentin et ai, 1992a) , and renders this technique especially suitable for Z determination. The peaks of N-glycans of a given charge are mostly comprised in distinct groups of peaks that are well separated from each other (Figure 1 ). This enables to assign the N-glycan composition according to neutral (asialo), mono-, di-, tri-, and tetrasialo-structures, i.e., N-glycans with zero to four negatively charged sialic acid residues (Conradt etai, 1991; Hermentin et ai, 1992a; Hermentin and Witzel, 1993) .
Particularly helpful is the use of two internal standards of which the first one (SI = e.g., LNnT or LNFP-V) elutes before, and the second one [S2 = (Neu5Ac)3] elutes after the distinct peaks of the N-glycan pool. Thus, the N-glycans detected between the two standards normally amount to the total peak area of the glycan pool, which is set equal to 100%. Similarly, the areas of the groups of peaks of a distinct charge are calculated via the chromatography software and expressed as the percentage of the total peak area.
Here we show that the mapping profiles of protein N-glycan pools obtained via HPAE-PAD can be used to calculate the 'hypothetical N-glycan charge Z,' which may be regarded as a new and helpful number that characterizes protein N-glycosylation. Z allows one to compare the glycosylation of various glycoproteins, to check the lot-to-lot consistency of recombinant glycoproteins, and to predict their in vivo clearance rates, relative to an appropriate standard preparation, and thus enables, to a certain extent, evaluation of their respective therapeutic efficacy and safety. This again may reduce the need for the very costly and timeconsuming and quite inaccurate in vivo bio-assays, a reduction that will also protect animals.
Thus, the hypothetical N-glycan charge Z of a glycoprotein may be regarded as a new and very helpful parameter that enables evaluation of the protein glycosylation in a simple, however, efficient manner.
Similarly, it is predicted that the hypothetical N-glycan charge can be used as a diagnostic tool in those cases where the glycosylation varies with the status of the disease, e.g., disease-related inflammations (a r acid glycoprotein; see De Graafera/., 1993; Mackiewicz and Mackiewicz, 1995) , hepatocellular carcinoma (a-fetoprotein; see Aoyagi, 1995) , ovarian cancer (a,-proteinase inhibitor and haptoglobin; see Turner et ai, 1995) , colorectal cancer (see Shahangian et ai, 1991) , cerebrospinal fluid leakage and alcohol abuse (transferrin; see De Jong et ai, 1995) , in Tamm-Horsfallrelated diseases (see Hard etai, 1992) , or in cancers where circulating blood group related carbohydrate antigens are regarded as tumor markers (see Shahangian et ai, 1991; Orntoft and Bech, 1995) (for a comprehensive review, see Turner, 1992) .
Materials and methods

Chemicals
The chemicals used for automated hydrazinolysis were purchased from Oxford GlycoSystems, Abingdon, England.
The internal standards LNnT and LNFP-V were also purchased from Oxford GlycoSystems, Abingdon, England. LNnT was also kindly provided by Dr. Ed McGuire, NEOSE Pharmaceuticals, Inc., Horsham, PA, USA). (Neu5 Ac) 3 was prepared from colominic acid (Sigma) as previously described (Hermentin etai., 1992a) Glycoproteins Rhu IL-4R (CHO) and rmur IL-4R (BHK) (lot 018PP) were developmental products of Behringwerke AG. Rhu EPO (BHK) and rhu EPO (CHO) were from Merckle AG (Ulm, Germany) and Boehringer Mannheim GmbH (Penzberg, Germany), respectively. The following human serum glycoproteins were products of Behringwerke AG (Marburg, Germany): AGP (lot no. 281184),antithrombin III (lot no. 244711), a,T-glycoprotein (lot no. 120891), a,-antitrypsin (lot no. 030179), a,-antichymotrypsin (lot no. 041181), /3 2 -glycoprotein I (lot no. 768), TBG-glycoprotein (lot no. 81641), a,B-glycoprotein (lot no. 3525), ex 2 HS-glycoprotein (lot no. 369/L6), 8Sarg'ycoprotein (lot no. 270792/1 A), haptoglobin (lot no. 3525). Bovine serum fetuin and fetal calf serum fetuin were from Sigma.
Hydrazinolysis-derived N-glycan pools
Hydrazinolysis was performed as previously described (Hermentin, 1993; Hermentin el al., 1994) , using an automated glycan release and recovery apparatus (GlycoPrep 1000, Oxford GlycoSystems, Abingdon, England). The N-glycan pools were desalted via a column of Sephadex G-25 superfine (Pharmacia) (column size 21 X 1 cm).
The following hydrazinolysis-derived glycan pools were purchased from Oxford GlycoSystems for measurements by HPAE-PAD: ribonuclease B from bovine pancreas (LB-009), human serumtransferrin (LB-010), porcine thyroglobulin (LB-011). human fibrinogen (LB-012), chicken ovomucoid(LB-013).
PNGase F-derived N-glycan pools
EPO. The liberation by PNGase F of the N-glycans of rhu EPO was performed as described by Nimtz et al. (1993) .
AGP. In a first series of experiments, AGP was digested with trypsin prior to digestion with PNGase F, as previously described (Hermentin et al.. 1992b) . In a second series of experiments. AGP was directly digested with PNGase F, applying the conditions used for rhu EPO, in order to achieve incomplete digestion.
IL-4R. The liberation by PNGase Fof the N-glycans of rhu IL-4R (CHO) (500 /xg) was achieved after reduction with dithioerythrol (25 fi\ of aq. 0.3 M DTE: 10 min at 70°C). Excess of DTE was removed by concentration/ washing (with digestion buffer) in Centricon tubes (10,000 D, Amicon). The concentrated material was digested with PNGase F (Boehringer Mannheim, 5 units) in 50 mM sodium phosphate buffer pH 7.6 (500 yu. 1), 48 h, 37°C (Eppendorf vials), with or without the presence of 0.5% CHAPS. The mixture was desalted via Sephadex G-25 superfine (Pharmacia) (column size 21 X 1 cm).
Monosaccharide and sialic acid determination
Monosaccharides were hydrolyzed in 2 N trifluoroacetic acid at IOO°C for 4 h and measured via HPAE-PAD in analogy to the procedure described by Hardy etal. (1988) . Neu5Ac was determined via HPAE-PAD as earlier described (Hermentin and Seidat. 1991) .
Mapping by HPAE-PAD
The glycan pools were measured by HPAE-PAD. using the set-up and the optimized standard gradient'S' for sialylated glycans previously described (Hermentin etal.. 1992a) .
Determination ofZ
The hypothetical N-glycan charge of the glycoproteins was gained by (i) liberating the N-glycan-pool of the glycoprotein via hydrazinolysis or PNGase F; (ii) measuring the N-glycan pool via HPAE-PAD; (iii) calculating the percentage of the areas (A) of the groups of peaks, separated by charge; (iv) multiplying the area% of the peak-groups in the neutral (asialo-. as), monosialo-(MS). disialo-(DiS). trisialo-(TriS). tetrasialo-(TetraS) and pentasialo (PentaS) region by zero (asialo), 1 (MS), 2 (DiS), 3 (TriS). 4 (TetraS), and 5 (PentaS). respectively: and (v) summarizing the respective products.
Thus. Z was defined as the sum of the products of the respective areas (A) in the asialo (as), monosialo (MS), disialo (DiS). trisialo (TriS). tetrasialo (TetraS), and pentasialo (PentaS) region, each calculated as the percentage of the total peak area set equal to 100%, and each multiplied by the corresponding charge: 
Validation experiments Z and the validity of automated hydrazinolysis, using rhu IL-4R (CHO).
Rhu IL-4R (CHO), produced in two different cell lines (E4 and B11) under identical culture and work-up conditions (lots no. E4-930914 and 811 -930406, respectively; unpublished results), was subjected to automated hydrazinolysis in the presence of LNnT or LNFP-V as internal standard in 3 x 6 distinct experiments, using 0.5 mg of glycoprotein per hydrazinolysis reactor, each. Alternatively, E4-930914 was measured in six distinct experiments, using 1.0 mg of glycoprotein per reactor. Each N-glycan pool was desalted via Sephadex G-25 superfine and measured via HPAE-PAD three times at three different days. A reference chromatogram is shown in Figure  1 : the determination of Z is outlined in Table I .
Z and the validity of PNGase F digestions, using rhu IL-4R (CHO)
The two samples of rhu IL-4R (Lots no. E4-930914 and B11 -930406) were digested with PNGase F (see PNGase F-derived N-glycan pools) , in the presence or absence of 0.5% CHAPS. Lot E4-930914 was further used to compare the PNGase F digest after previous digestion with trypsin or Lys C (Table II) , applying the conditions previously described for the tryptic digestion of AGP (Hermentin et al., 1992b) .
Z and the PNGase F digestion of A GP. AGP was digested with PNGase F for a period of 48 h, applying the conditions described for rhu EPO (Nimtz et al.. 1993) , in order to achieve incomplete N-glycan release. Z was compared with the value obtained via hydrazinolysis as well as with the value obtained via PNGase F digestion of a tryptic AGP digest (Hermentin et al., 1992b) (Figure 2 ).
Z and the consistency control of protein glycosylalion
Z and the comparison of various A GP-derived N-glycan pools. Two manual "large scale" hydrazinolysis-derived N-glycan pools (from 50 mg and 1000 mg of AGP, lot no. 281184), an automated hydrazinolysis (GlycoPrep 1000)-derived N-glycan pool, and a fourth hydrazinolysis-derived N-glycan pool of AGP, purchased from Oxford GlycoSystems (Cat. No. LB-001; derived from AGP. produced at Sigma), were previously compared with the PNGase F-derived N-glycan pool of AGP, by comparison of their respective HPAE-PAD chromatograms (Hermentin et al., 1992b) . These HPAE-PAD chromatograms have now been reprocessed (about 3 years later) in order to enable their comparison via Z determination.
Z and the lot-to-lot consistency of rhu IL-4R. Samples of culture supernatants of rhu IL-4R (CHO) production in a pilot plant (unpublished data) were purified on a column of immobilized monoclonal anti-rhu IL-4R antibody (mAb 971 /134-Sepharose 4B). After extensive washing with PBS pH 7.2 + 0.5% Triton X-100 and PBS pH 7.2, rhu IL-4R was eluted with 0.1 mol/litre glycine-HCl pH 2.5. The eluate was neutralized immediately with 2 mol/litre Tris-HCl pH 8.0, concentrated by ultrafiltration, and dialyzed against PBS pH 7.2. Alternatively, the cell culture supernatants were worked-up via a series of chromatographic steps (unpublished procedure). The isolates were routinely analyzed with respect to the lot-to-lot consistency of the protein glycosylation. using Neu5Ac and Z determination as the appropriate parameters. The results are summarized in Table III .
Z and the glycoprotein clearance in vivo, exemplified with rmur IL-4R (BHK)
Purification ofrmurlL-4R (BHK). Rmur IL-4R (BHK) was purified from culture supernatant by immunoaffinity chromatography on immobilized monoclonal anti-rmur IL-4R antibody (mAb Ml-Sepharose 4B). After extensive washing with PBS pH 7.2 + 0.5% Triton X-100 and PBS pH 7.2. rmur IL-4R was eluted with 0.1 mol/litre dibasic sodium phosphate-NaOH pH 11.5. The eluate was neutralized immediately with 1 mol/litre monobasic sodium phosphate-NaOH pH 5.5. concentrated by ultrafiltration and dialyzed against PBS pH 7.2.
Fractionation of rmur IL-4R bv anion-exchange chromatography and
analysis of the fractions. Rmur IL-4r(BHK)(21 mg;lot018PP)in20mmol/ litre Tris-HCl pH 7.5 (buffer A) was loaded on a column (1 X 10 cm) of Q-Sepharose FF equilibrated with buffer A. Protein waseluted with a linear gradient from 50 mmol/litre to 300 mmol/litre sodium chloride in buffer A at a linear flow rate of 76 ml/h; 1 ml fractions were collected and pooled as shown in Figure 3 . The sialic acid content, expressed as Neu5Ac/peptide bone (mol/mol), the degree of sialylation. expressed as Neu5Ac/Gal (mol/ mol), as well as the presence of high-mannose type structures, expressed as Man/Gal (mol/mol). was determined for each fraction and compared with the respective Z value, which is summarized in Table IV . Horizontal IEF of the samples (40 /xl; 5-7 mg/ml) was performed in slab polyacrylamide gels (T5C5.1) with a gradient from pH 3.5 to 6.0 (Pharmacia Ampholines 3.5-5.0 and 4.0-6.0,1 + 1). After IEF the gel was stained with ServaBlue-G and scanned, using a Molecular Dynamics (Sunnyvale, CA 94086) MD 300A imaging system equipped with the Discovery One software from PDI (Protein and DNA ImageWare Systems, Huntington Station, NY) (Figure 4) .
In vivo clearance studies with rmur IL-4R. The rate of clearance of rmur IL-4R (BHK) was determined as follows. Female BALB/C mice received an intravenous bolus injection of IL-4R (10 /u.g, 0.2 Mg/kg) v ' a tne ta '' ve ' nFive, 10 and 30 min after application, blood was withdrawn by puncture of the retroorbital vein complex, and serum was prepared. Thereafter the concentration of IL-4R in serum samples was measured by an ELISA assay (unpublished data). The area under the serum concentration versus time data (AUD5.30) was calculated by application of the trapezoidal rule (Ritschel, 1983) , and the initial clearance of IL-4R (CI 5 _ W ) was calculated according to the formula: CI 5 _ M = Dose/AUD 5 _3o, which is summarized in Table IV .
Z and the IL-4R stability upon storage
Culture supernatants containing rhu IL-4R (CHO) were stored at various temperatures (RT, +4°C, -20°C, and -70°C) over a period of 3 months. Samples were taken at day zero and after 1,2,3,4,8, and 12 weeks of storage and affinity-purified on immobilized monoclonal anti-rhu IL-4R antibody (mAb 971/134-Sepharose 4B). After extensive washing with PBS pH 7.2 + 0.5% Triton X-100 and PBS pH 7.2, rhu IL-4R was eluted with 0.1 mol/ litre glycine-HCl pH 2.5. The eluate was neutralized immediately with 2 mol/litre Tris-HCl pH 8.0, concentrated by ultrafiltration and dialyzed against PBS pH 7.2, in order to enable sialic acid as well as (after automated hydrazinolysis) Z determination. The results are summarized in Figure 5 .
Z determination of distinct glycoproteins
The glycan pools isolated from various glycoproteins via hydrazinolysis or PNGase F treatment, as summarized in Table V . were separated via HPAE-PAD, using the standard gradient 'S' previously described (Hermentin et al., 1992a) . The human serum glycoproteins were subjected to automated hydrazinolysis in amounts of 2 mg per reactor each and were mapped via HPAE-PAD without any further desalting. The various glycan pools that were purchased from OGS were dissolved in water and analogously measured by HPAE-PAD without any prior desalting. The mapping profiles of these OGS samples, which have been communicated previously (Hermentin and Witzel, 1993) , were recalculated for Z determination (Table V) .
